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An increasingly strong body of evidence implicates the air-
way epithelium as a critical regulator of airway inﬂammation
and remodeling relevant to the pathogenesis of asthma.
The evidence implicating the epithelium includes in vivo
studies in humans and in murine models as well as in
vitro studies conducted with primary epithelial cells. The
purposeofthisspecialissueistoprovideaforumtointegrate
new knowledge about the nature of epithelial dysfunction
in asthma and examine the role of the epithelium as a
regulator of immune function. The articles contained within
this special issue expound upon human studies examining
epithelial gene expression, alterations in epithelial structure,
as well as in vitro studies investigating epithelial function
relevant to asthma.
This special issue contains 3 original research articles and
4 review articles including some that delineate larger bodies
of work by well-established research labs. The review articles
focus on mechanisms related to the epithelium including the
response to fungal allergens, epithelial apoptosis, production
of mediators involved in remodeling of the matrix, and the
important role of epithelial injury and the production of IL-
25 in the induction phase of asthma. Two of the research
articles highlight pathways of epithelial activation leading
to inﬂammation that diverges from the traditional Th2
paradigm. In the ﬁnal research article, the authors examine
the utility of in vitro epithelial models.
In the paper entitled “Mechanisms of remodeling in
asthmatic airways,” A. Shifren et al. from the group at
Washington University including Dr. Mario Castro and
others present an overview of structural changes that occur
in patients with asthma and are particularly prominent
in patients with severe asthma. In particular, their review
outlines several mechanisms of epithelial activation leading
to these structural changes in the subepithelial matrix as
well as mucous cell alterations leading to further airﬂow
obstruction. The roles of various therapies that may target
remodeling are discussed.
In the paper “Apoptosis and the airway epithelium,” S. R.
White from the University of Chicago presents a thorough
overview of the function of epithelial apoptosis in health and
diseasestatesfocusingonasthma,butalsoextendingtoother
pulmonary diseases. The article has an outstanding overview
of the function of apoptosis in the epithelium in contrast
to immune cells and the basic mechanisms that regulate
apoptosis in the epithelium. The article clearly delineates
alterations in apoptosis that have been identiﬁed in human
studies and in vivo animal models and the reasons that these
alterations in the epithelium may play a pathogenic role in
asthma and other lung diseases involving the epithelium.
In the paper “Responses of airway epithelium to envi-
ronmental injury: role in the induction phase of childhood
asthma,” R. K. Kumar and others from the University of
New South Wales along with P. Foster and others from the
University of Newcastle present a detailed picture of the
factors involving the epithelium that may initiate airway
inﬂammation. In particular, the response of the epithelium2 Journal of Allergy
to viral infection and environmental pollutants such as
diesel exhaust particles are presented as common triggers
that occur in the epithelium leading to the generation of
important epithelial factors including interleukin 25 (IL-
25) and thymic stromal lymphopoietin (TSLP). The authors
present evidence from their own work and others using
studies in epithelial model systems as well as in vivo studies.
The ﬁnal review article “Immunopathology and immuno-
genetics of allergic bronchopulmonary aspergillosis,” was writ-
ten by A. P. Knutsen from the Department of Pediatrics at
Saint Louis University. The review focuses on the patho-
genesis of allergic bronchopulmonary aspergillosis (ABPA),
a disease characterized by fungal hypersensitivity associated
with central bronchiectasis and markedly elevated IgE. By
relating a signiﬁcant body of work relating to the epithelial
response to aspergillus and other mold antigens, the author
presents compelling evidence that the epithelium plays a key
role in the pathogenesis of ABPA by regulating lymphocyte
traﬃcking and activation.
In the original research article titled, “Immunolocal-
ization of NLRP3 inﬂammasome in normal murine airway
epithelium and changes following induction of ovalbumin-
induced airway inﬂammation,” H. B. Tran et al. from the
University of Adelaide use the murine model of ovalbumin-
induced airway inﬂammation to examine the activation of
the NLRP3 inﬂammasome in the airway epithelium. Little
is known about the activation of this aspect of the innate
immune system in asthma or model systems of asthma.
In the epithelium, the authors found evidence of active
caspase-1 and a redistribution of caspase-1, IL-1β,a n dI L
18 towards the luminal surface following sensitization and
challenge with ovalbumin. These intriguing results should
spur more research into triggers of asthma that may lead
to inﬂammasome activation and the speciﬁc role of the
inﬂammasome in models of asthma.
In the research paper “IL-17F induces CCL20 in bronchial
epithelial cells,” K. Nozato et al. examine the regulation of
CCL20 expression by IL-17F in bronchial epithelial cells.
The authors demonstrate that IL-17F modulates CCL20
expression through a mitogen-activated protein kinase
(MAPK) pathway leading to the activation of the cyclic
AMPresponseelement-binding(CREB)transcriptionfactor.
This paper adds to other evidence by this investigative team
demonstrating that IL-17F induces CXC chemokines, GM-
CSF, IP-10, IL-11, and IGF-1 through this pathway.
In the ﬁnal research paper “Evaluation of diﬀerentiated
human bronchial epithelial cell culture systems for asthma
research,” C. F. Stewart et al. from the University of Notting-
ham working with I. Sayers evaluated diﬀerences between
in vitro models of the epithelium. The investigators used
p r i m a r yh u m a nb r o n c h i a le p i t h e l i a lc e l l sa sw e l la ss e v e r a l
cell lines including a lung adenocarcinoma cells line (Calu-
3) and SV-40-transformed human bronchial epithelial cells
(BEAS-2B). Using these cells they found that there were
diﬀerences in markers of diﬀerentiation such as mucous
cell diﬀerentiation between the cultured cells, as well as
diﬀerencesbetweenthejunctionproteins.Althoughthebasis
of the diﬀerences are is know in detail, the research found
that there were diﬀerences between primary epithelial cells
donor as well as between cultures that originated from the
samedonorraisingimportantquestionsaboutthevariability
of these model systems.
Takentogether,thesearticlesprovideyetfurtherevidence
thatinasthmatheepitheliumtakescenterstageinorchestrat-
ing responses to the inhaled environment through pathways
inﬂuencing inﬂammation as well as aberrant repair. In
addition, the epithelium provides a platform for identifying
novel therapeutic targets linked to increasing the resistance
of the airways to environmental injury. We are exceedingly
grateful to the many leaders in the ﬁeld of epithelial biology
and asthma who have contributed to this special issue. The
strong response to this call for papers by well-recognized
researchers in this ﬁeld provides additional evidence of the
emerging importance of the ﬁeld of epithelial biology to the
understanding of asthma.
Teal S. Hallstrand
Prescott G. Woodruﬀ
Stephen T. Holgate
Darryl A. Knight